Vertebral compression fractures are one of the most common injuries of the spine and can be caused by trauma, osteoporosis, and pathological causes. It is more common in the elderly because most of them have osteoporosis, and sometimes a small force can cause a vertebral compression fracture, such as during improper positioning or housework, or even coughing or sneezing, which can cause severe pain in the lower back, making the elderly unable to care for themselves or even bedridden. For vertebral compression fractures in the elderly without spinal cord compression symptoms, minimally invasive treatment can achieve excellent results. Currently, the main treatments are percutaneous vertebroplasty (PVP) and percutaneous kyphoplasty (PKP). Percutaneous vertebroplasty (PVP) is a minimally invasive spine surgery technique that involves the percutaneous injection of bone cement into the vertebral body through the vertebral arch or outside the vertebral arch to increase the strength and stability of the vertebral body, prevent collapse, relieve pain, and even partially restore the height of the vertebral body. PVP was first used in the United States in 1994 and has now become a common method for the treatment of painful vertebral disorders. In recent years, the application of percutaneous vertebroplasty has gradually spread and is more often applied to patients with osteoporotic vertebral compression fractures with intractable pain, in addition to spinal hemangiomas, myeloma, and osteolytic metastases. As the survival time of patients with tumor metastases increases, so do their requirements for quality of life and the ability to be active in the final stages of the disease. In patients with spinal metastases, PVP has been reported to relieve pain and structurally strengthen the osteolytically damaged vertebral body, allowing patients to experience less pain and to continue daily weight-bearing activities. Percutaneous kyphoplasty (PKP) is a modification and development of percutaneous kyphoplasty, which uses percutaneous puncture to reposition the vertebral body by intra-vertebral balloon expansion, creating a space inside the vertebral body, which reduces the pushing force required for cement injection and makes the cement less likely to flow, thus greatly reducing the incidence of cement leakage complications. There is no difference between the biomechanical properties of this method and the conventional method. Clinical application shows that it can not only relieve or relieve pain symptoms, but also significantly restore the height of the compressed vertebral body, increase the stiffness and strength of the vertebral body, restore the physiological curvature of the spine, and increase the volume of the thoracoabdominal cavity and improve the function of the organs, thus improving the quality of life of patients. Indications: (1) painful osteoporotic vertebral compression fractures that have failed to respond to drug therapy; (2) painful vertebral fractures associated with osteonecrosis; (3) unstable compression fractures; (4) multiple osteoporotic vertebral compression fractures that result in posterior convexity deformity and cause changes in pulmonary and gastrointestinal function and center of gravity; (5) chronic traumatic fractures with non-union or internal cystic changes (6) acute traumatic fractures without neurological symptoms (7) vertebral tumors without spinal cord symptoms, such as vertebral hemangioma, myeloma, primary and metastatic malignant tumors of the vertebral body, and some benign vertebral tumors Absolute contraindications: (1) asymptomatic stable fractures; (2) patients with significant improvement after pharmacologic treatment; (3) prophylactic treatment in patients without evidence of acute fracture; (4) uncorrected coagulation disorders and bleeding constitution. (5) Osteomyelitis in the target vertebra; (6) Hypersensitivity to any of the items required for the procedure. Relative contraindications: (1) radicular pain that significantly exceeds that of the vertebral body, caused by a compression syndrome unrelated to vertebral body collapse; (2) significant spinal canal compression due to regression of the fracture mass; (3) severe vertebral body collapse; (4) stable fractures that are painless and more than 2 years old; (5) 3 or more segments treated simultaneously at one time. Vertebral tumors were the first subjects to be treated with percutaneous vertebroplasty, and excellent results were achieved. At present, percutaneous vertebral body kyphoplasty is mainly used for the treatment of osteoporotic vertebral compression fractures, and the reported pain relief rates are over 90%, with few serious complications, and their good efficacy and high safety are recognized by the majority of doctors and patients. It greatly improves the quality of life of tumor patients and facilitates further chemotherapy and radiotherapy.